A novel DNA-free gene editing platform using ribonucleoprotein complexes (RNPs) delivered via laser-mediated transformation to induce targeted chromosomal inversions in vegetable crops. This approach enables precise, foreign-DNA-free edits with high mutation efficiency, supporting trait development without off-target integration.
This offering presents a novel DNA-free genome editing method for inducing targeted gene inversions in vegetable crops. The technology leverages the delivery of ribonucleoprotein complexes (RNPs) into plant cells using a proprietary laser-mediated transformation method, with biolistic transformation as a backup. By introducing double-strand DNA breaks at two positions flanking a gene of interest, the approach exploits spontaneous DNA recombination events to generate chromosomal inversions—a technique known as chromosome engineering. This method enables precise genetic modifications without introducing foreign DNA into the host genome, making it particularly attractive for breeding programs and trait development in vegetable crops.
Key features:
How it works:
The process involves designing RNPs that target two regions flanking the gene of interest, producing a double cut in the genome. Spontaneous recombination events then lead to the desired inversion at low frequency. Transformed tissue explants are cultured to regenerate plantlets, which are subsequently screened and crossed to obtain homozygous mutants.
The laser-mediated DNA-free gene editing method has been validated in tobacco for gene knockout applications. The chromosome engineering concept—inducing large DNA fragment inversions via double-strand breaks—has been previously validated by other research groups in Arabidopsis and maize. The current proposal aims to extend this approach to vegetable crops through four experimental phases: (1) establishing plant regeneration protocols, (2) performing RNP transformation and tissue culture, (3) characterizing mutants via PCR and deep sequencing, and (4) growing and selecting homozygous mutants in greenhouses. Final mutant plants will be transferred to the sponsoring company for further evaluation.
Fraunhofer is a large, multi-site applied research organization based in Germany, operating a nationwide network of institutes and research units with a strong industry-facing mission. Its contract-research model aligns work to real manufacturing and deployment needs, with pilot lines, test labs, and demonstration facilities for validation and scale-up. Many institutes are integrated with nearby universities and regional industry clusters, enabling joint appointments, shared infrastructure, and fast talent pipelines. Research is supported by competitive European programs alongside German federal and state funding, complemented by extensive contract revenue from private-sector collaborations. A dedicated technology transfer function manages IP, licensing, and startup formation.